Iterum Therapeutics plc (ITRMF) Accumulated Depreciation (2017 - 2025)

Iterum Therapeutics' Accumulated Depreciation history runs 9 years deep, the most recent figure standing at $91000.0 for Q3 2025.

• In Q3 2025, Accumulated Depreciation fell 72.67% year-over-year to $91000.0; the TTM figure through Sep 2025 stood at $91000.0 (down 72.67% YoY), while the FY2024 annual figure was $340000.0, up 7.94% from the prior year.
• Accumulated Depreciation for Q3 2025 stood at $91000.0, down from $308000.0 in the prior quarter.
• The five-year high for Accumulated Depreciation was $845000.0 in Q3 2021, with the low at $91000.0 in Q3 2025.
• The 5-year median for Accumulated Depreciation is $308000.0 (2025), against an average of $356631.6.
• The sharpest annual moves came in 2021 and 2025: Accumulated Depreciation surged 77.89% in 2021, then sank 72.67% in 2025.
• Iterum Therapeutics' Accumulated Depreciation stood at $286000.0 in 2021, then decreased by 0.7% to $284000.0 in 2022, then climbed by 10.92% to $315000.0 in 2023, then rose by 7.94% to $340000.0 in 2024, then plunged by 73.24% to $91000.0 in 2025.
• Business Quant data shows ITRMF's Accumulated Depreciation at $91000.0 in Q3 2025, $308000.0 in Q2 2025, and $302000.0 in Q1 2025.